PI3 and breast carcinoma: To interrogate the significance of elafin expression in luminal breast cancer cell lines we generated MCF-7 and T47D cells expressing either wild-type elafin or elafin M25G, bearing a mutation in the protease inhibitory rendering it incapable of protease inhibition [24]; cells expressing GFP were used as a control (Figure 6D).